Crossmark

A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s00280-014-2527-4

Published Online: 2014-07-18

Published Print: 2014-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Ikeda, Takaya

Fukuda, Minoru

Nakamura, Yoichi

Kinoshita, Akitoshi

Senju, Hiroaki

Nakano, Hirofumi

Kitazaki, Takeshi

Ogawara, Daiki

Taniguchi, Hirokazu

Motoshima, Kohei

Yamaguchi, Hiroyuki

Nakatomi, Katsumi

Shimada, Midori

Nagashima, Seiji

Tsukamoto, Kazuhiro

Kohno, Shigeru
License Information

Text and Data Mining valid from 2014-07-18